Stocks · Health care · Pharmaceutical Preparations

Climb Bio, Inc.

CLYM Clue Score37

United States Fiscal year ends December CIK 0001768446 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

By person

4 insiders · 13 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Stephen Basil Thomas

Director

—

$2.25M (5) scheduled

−$2.25M

467,969

0.8148%

$6.40M

−9.5%

Ra Capital Management, L.p. entity

Director

$779.63K (3)

—

+$779.63K

4,244,516

7.39%

$58.01M

−82.5%

Aoife Brennan

President and CEO

—

$406.98K (1) scheduled

−$406.98K

87,731

0.1527%

$1.20M

+4,910%

Emily Pimblett

SVP, Finance & CAO

—

—

—

18,888

0.0329%

$258.16K

+149.7%